A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC)

R. Erlandsson, U. S.R. Bergerheim, F. Boldog, Z. Marcsek, K. Kunimi, B. Y.T. Lin, S. Ingvarsson, J. S. Castresana, W. H. Lee, E. Lee, G. Klein, J. Sumegi

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Renal Cell Carcinoma (RCC) has been associated with the loss of heterozygosity at several loci on the short arm of chromosome 3 (3p). We have previously found that one of these loci, D3F15S2 (pH3H2) was lost in 76% of the tumor cells derived from heterozygous donors (Kovacs, G., Erlandsson, R., Boldog, F., Ingvarsson, S., Muller-Brechlin, R., Klein, G. and Sumegi, J. (1988), Proc. Natl. Acad. Sci., 85, 1571-5). More recently we have identified a putative CpG island in the vicinity of D3F15S2, suggesting that DNA sequences in or around this site may have coding potential (Boldog, F., Erlandsson, R., Klein, G. and Sumegi, J. (1989). Cancer Genet, Cytogenet., 42, 295-306). The screening of a human placenta cDNA library with DNA probes derived from D3F15S2 has led to the isolation of several cDNA clones. They identified a 2.9 Kb long message in human placenta and kidney. In total RNA from 11 of 15 primary RCCs the gene expression was reduced to less than 20% compared to eight normal kidneys. This low level of expression may be due to contaminating normal tissue. In the remaining 4 tumors the expression varied from 24-51% compared to normal kidney. To facilitate reference, the gene was provisionally designated as 'RIK'. It was expressed in the HEK 293, one osteosarcoma (HOS), two carcinoma (COLO320 and QDMT), and three Burkitt lymphoma lines (BL2, BL29 and BL31). It was not expressed in one Burkitt lymphoma (DG75) and two EBV transformed lymphoblastoid cell lines (LCL) (NAD-20 and Cherry).

Original languageEnglish (US)
Pages (from-to)1207-1211
Number of pages5
JournalOncogene
Volume5
Issue number8
StatePublished - Sep 5 1990

Fingerprint

Renal Cell Carcinoma
Burkitt Lymphoma
Kidney
Placenta
Genes
Viverridae
Neoplasms
Transformed Cell Line
CpG Islands
Chromosomes, Human, Pair 3
Loss of Heterozygosity
DNA Probes
Osteosarcoma
Human Herpesvirus 4
Gene Library
NAD
Complementary DNA
Clone Cells
RNA
Carcinoma

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Erlandsson, R., Bergerheim, U. S. R., Boldog, F., Marcsek, Z., Kunimi, K., Lin, B. Y. T., ... Sumegi, J. (1990). A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC). Oncogene, 5(8), 1207-1211.

A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC). / Erlandsson, R.; Bergerheim, U. S.R.; Boldog, F.; Marcsek, Z.; Kunimi, K.; Lin, B. Y.T.; Ingvarsson, S.; Castresana, J. S.; Lee, W. H.; Lee, E.; Klein, G.; Sumegi, J.

In: Oncogene, Vol. 5, No. 8, 05.09.1990, p. 1207-1211.

Research output: Contribution to journalArticle

Erlandsson, R, Bergerheim, USR, Boldog, F, Marcsek, Z, Kunimi, K, Lin, BYT, Ingvarsson, S, Castresana, JS, Lee, WH, Lee, E, Klein, G & Sumegi, J 1990, 'A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC)', Oncogene, vol. 5, no. 8, pp. 1207-1211.
Erlandsson, R. ; Bergerheim, U. S.R. ; Boldog, F. ; Marcsek, Z. ; Kunimi, K. ; Lin, B. Y.T. ; Ingvarsson, S. ; Castresana, J. S. ; Lee, W. H. ; Lee, E. ; Klein, G. ; Sumegi, J. / A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC). In: Oncogene. 1990 ; Vol. 5, No. 8. pp. 1207-1211.
@article{c1e7258304f5481fb4c04e472a356913,
title = "A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC)",
abstract = "Renal Cell Carcinoma (RCC) has been associated with the loss of heterozygosity at several loci on the short arm of chromosome 3 (3p). We have previously found that one of these loci, D3F15S2 (pH3H2) was lost in 76{\%} of the tumor cells derived from heterozygous donors (Kovacs, G., Erlandsson, R., Boldog, F., Ingvarsson, S., Muller-Brechlin, R., Klein, G. and Sumegi, J. (1988), Proc. Natl. Acad. Sci., 85, 1571-5). More recently we have identified a putative CpG island in the vicinity of D3F15S2, suggesting that DNA sequences in or around this site may have coding potential (Boldog, F., Erlandsson, R., Klein, G. and Sumegi, J. (1989). Cancer Genet, Cytogenet., 42, 295-306). The screening of a human placenta cDNA library with DNA probes derived from D3F15S2 has led to the isolation of several cDNA clones. They identified a 2.9 Kb long message in human placenta and kidney. In total RNA from 11 of 15 primary RCCs the gene expression was reduced to less than 20{\%} compared to eight normal kidneys. This low level of expression may be due to contaminating normal tissue. In the remaining 4 tumors the expression varied from 24-51{\%} compared to normal kidney. To facilitate reference, the gene was provisionally designated as 'RIK'. It was expressed in the HEK 293, one osteosarcoma (HOS), two carcinoma (COLO320 and QDMT), and three Burkitt lymphoma lines (BL2, BL29 and BL31). It was not expressed in one Burkitt lymphoma (DG75) and two EBV transformed lymphoblastoid cell lines (LCL) (NAD-20 and Cherry).",
author = "R. Erlandsson and Bergerheim, {U. S.R.} and F. Boldog and Z. Marcsek and K. Kunimi and Lin, {B. Y.T.} and S. Ingvarsson and Castresana, {J. S.} and Lee, {W. H.} and E. Lee and G. Klein and J. Sumegi",
year = "1990",
month = "9",
day = "5",
language = "English (US)",
volume = "5",
pages = "1207--1211",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC)

AU - Erlandsson, R.

AU - Bergerheim, U. S.R.

AU - Boldog, F.

AU - Marcsek, Z.

AU - Kunimi, K.

AU - Lin, B. Y.T.

AU - Ingvarsson, S.

AU - Castresana, J. S.

AU - Lee, W. H.

AU - Lee, E.

AU - Klein, G.

AU - Sumegi, J.

PY - 1990/9/5

Y1 - 1990/9/5

N2 - Renal Cell Carcinoma (RCC) has been associated with the loss of heterozygosity at several loci on the short arm of chromosome 3 (3p). We have previously found that one of these loci, D3F15S2 (pH3H2) was lost in 76% of the tumor cells derived from heterozygous donors (Kovacs, G., Erlandsson, R., Boldog, F., Ingvarsson, S., Muller-Brechlin, R., Klein, G. and Sumegi, J. (1988), Proc. Natl. Acad. Sci., 85, 1571-5). More recently we have identified a putative CpG island in the vicinity of D3F15S2, suggesting that DNA sequences in or around this site may have coding potential (Boldog, F., Erlandsson, R., Klein, G. and Sumegi, J. (1989). Cancer Genet, Cytogenet., 42, 295-306). The screening of a human placenta cDNA library with DNA probes derived from D3F15S2 has led to the isolation of several cDNA clones. They identified a 2.9 Kb long message in human placenta and kidney. In total RNA from 11 of 15 primary RCCs the gene expression was reduced to less than 20% compared to eight normal kidneys. This low level of expression may be due to contaminating normal tissue. In the remaining 4 tumors the expression varied from 24-51% compared to normal kidney. To facilitate reference, the gene was provisionally designated as 'RIK'. It was expressed in the HEK 293, one osteosarcoma (HOS), two carcinoma (COLO320 and QDMT), and three Burkitt lymphoma lines (BL2, BL29 and BL31). It was not expressed in one Burkitt lymphoma (DG75) and two EBV transformed lymphoblastoid cell lines (LCL) (NAD-20 and Cherry).

AB - Renal Cell Carcinoma (RCC) has been associated with the loss of heterozygosity at several loci on the short arm of chromosome 3 (3p). We have previously found that one of these loci, D3F15S2 (pH3H2) was lost in 76% of the tumor cells derived from heterozygous donors (Kovacs, G., Erlandsson, R., Boldog, F., Ingvarsson, S., Muller-Brechlin, R., Klein, G. and Sumegi, J. (1988), Proc. Natl. Acad. Sci., 85, 1571-5). More recently we have identified a putative CpG island in the vicinity of D3F15S2, suggesting that DNA sequences in or around this site may have coding potential (Boldog, F., Erlandsson, R., Klein, G. and Sumegi, J. (1989). Cancer Genet, Cytogenet., 42, 295-306). The screening of a human placenta cDNA library with DNA probes derived from D3F15S2 has led to the isolation of several cDNA clones. They identified a 2.9 Kb long message in human placenta and kidney. In total RNA from 11 of 15 primary RCCs the gene expression was reduced to less than 20% compared to eight normal kidneys. This low level of expression may be due to contaminating normal tissue. In the remaining 4 tumors the expression varied from 24-51% compared to normal kidney. To facilitate reference, the gene was provisionally designated as 'RIK'. It was expressed in the HEK 293, one osteosarcoma (HOS), two carcinoma (COLO320 and QDMT), and three Burkitt lymphoma lines (BL2, BL29 and BL31). It was not expressed in one Burkitt lymphoma (DG75) and two EBV transformed lymphoblastoid cell lines (LCL) (NAD-20 and Cherry).

UR - http://www.scopus.com/inward/record.url?scp=0024990236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024990236&partnerID=8YFLogxK

M3 - Article

C2 - 2392324

AN - SCOPUS:0024990236

VL - 5

SP - 1207

EP - 1211

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 8

ER -